tiprankstipranks
Trending News
More News >
Aspira Women's Health (AWHL)
OTHER OTC:AWHL

Aspira Women's Health (AWHL) Stock Statistics & Valuation Metrics

Compare
201 Followers

Total Valuation

Aspira Women's Health has a market cap or net worth of $16.51M. The enterprise value is $6.46M.
Market Cap$16.51M
Enterprise Value$6.46M

Share Statistics

Aspira Women's Health has 43,480,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,480,410
Owned by Insiders12.95%
Owned by Institutions0.32%

Financial Efficiency

Aspira Women's Health’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count66
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Aspira Women's Health is ―. Aspira Women's Health’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio0.00
Price to Fair Value
Price to FCF0.00
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Aspira Women's Health had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue
Gross Profit
Operating Income
Pretax Income
Net Income
EBITDA
Earnings Per Share (EPS)

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share

Dividends & Yields

Aspira Women's Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.04
52-Week Price Change20.44%
50-Day Moving Average0.46
200-Day Moving Average0.36
Relative Strength Index (RSI)30.19
Average Volume (3m)100.39K

Important Dates

Aspira Women's Health upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date

Financial Position

Aspira Women's Health as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Aspira Women's Health has paid ― in taxes.
Income Tax
Effective Tax Rate

Enterprise Valuation

Aspira Women's Health EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Aspira Women's Health has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities
Total Debt
Net Cash
Net Cash Per Share
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Aspira Women's Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast4.17%
EPS Growth Forecast68.47%

Scores

Smart ScoreN/A
AI Score